24.04.2015 - US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)